Skip to main content
Top
Gepubliceerd in:
Omslag van het boek

2021 | OriginalPaper | Hoofdstuk

41. Pityriasis alba

Auteur : Annemarije Kruis

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Pityriasis alba kenmerkt zich door onscherp begrensde hypopigmentaties. Deze zijn meestal gelokaliseerd op het gelaat, maar kunnen ook voorkomen op de romp.
Literatuur
1.
go back to reference Maymone, M. B. C., Watchmaker, J. D., Dubiel, M., Wirya, S. A., Shen, L. Y., & Vashi, N. A. (2019). Common skin disorders in pediatric skin of color. Journal of Pediatric Health Care, 33, 727–737.CrossRef Maymone, M. B. C., Watchmaker, J. D., Dubiel, M., Wirya, S. A., Shen, L. Y., & Vashi, N. A. (2019). Common skin disorders in pediatric skin of color. Journal of Pediatric Health Care, 33, 727–737.CrossRef
2.
go back to reference Fenner, J., & Silverberg, N. B. (2018). Skin diseases associated with atopic dermatitis. Clinics in Dermatology, 36, 631–640.CrossRef Fenner, J., & Silverberg, N. B. (2018). Skin diseases associated with atopic dermatitis. Clinics in Dermatology, 36, 631–640.CrossRef
3.
go back to reference Miazek, N., Michalek, I., Pawlowska-Kisiel, M., Olszewska, M., & Rudnicka, L. (2015). Pityriasis alba-common disease, enigmatic entity: Up-to-date review of the literature. Pediatric Dermatology, 32(6), 786–791.CrossRef Miazek, N., Michalek, I., Pawlowska-Kisiel, M., Olszewska, M., & Rudnicka, L. (2015). Pityriasis alba-common disease, enigmatic entity: Up-to-date review of the literature. Pediatric Dermatology, 32(6), 786–791.CrossRef
4.
go back to reference Vinod, S., Singh, G., Dash, K., & Grover, S. (2002). Clinico epidemiological study of pityriasis alba. Indian Journal of Dermatology, Venereology and Leprology, 68, 338–340.PubMed Vinod, S., Singh, G., Dash, K., & Grover, S. (2002). Clinico epidemiological study of pityriasis alba. Indian Journal of Dermatology, Venereology and Leprology, 68, 338–340.PubMed
5.
go back to reference Fujita, W. H., McCormick, C. L., & Parneix, A. (2007). An exploratory study to evaluate the efficacy of pimecrolimus cream 1 % for the treatment of pityriasis alba. International Journal of Dermatology, 46, 700–705. Fujita, W. H., McCormick, C. L., & Parneix, A. (2007). An exploratory study to evaluate the efficacy of pimecrolimus cream 1 % for the treatment of pityriasis alba. International Journal of Dermatology, 46, 700–705.
6.
go back to reference Rigopoulos, D., Gregoriou, S., Charissi, C., et al. (2006). Tacrolimus ointment 0.1 % in pityriasis alba: an open-label, randomized, placebo-controlled study. British Journal of Dermatology, 155(1):152–155. Rigopoulos, D., Gregoriou, S., Charissi, C., et al. (2006). Tacrolimus ointment 0.1 % in pityriasis alba: an open-label, randomized, placebo-controlled study. British Journal of Dermatology, 155(1):152–155.
7.
go back to reference Di Lernia, V., & Ricci, C. (2006). Progressive and extensive hypomelanosis and extensive pityriasis alba: Same disease, different names? Journal of the European Academy of Dermatology and Venereology, 20(10), 1363–1364.CrossRef Di Lernia, V., & Ricci, C. (2006). Progressive and extensive hypomelanosis and extensive pityriasis alba: Same disease, different names? Journal of the European Academy of Dermatology and Venereology, 20(10), 1363–1364.CrossRef
Metagegevens
Titel
Pityriasis alba
Auteur
Annemarije Kruis
Copyright
2021
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2739-3_41